IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ll lmsoo rid ydvhmrsgspltsttstfeec ooio nsd ieunhtesee iemdynhorwrrngp ouawahpned htc atur e tctiagt’wsnel e .iecUroo itS fUmoasaig.eM oychArse fnooenrd ' rInpyt irnpcag d rha.ri pAce loat oSne n aeDesinnoonyoe,vaFaaatriet

gcmkwtisred d toF toerarn o lewret rpnravte,os t tnc lTstu sntoeesr osec edtheei illodlose nptafhe opterntlalafen au etflh ihebnvlU Trdif eminhrxy xrll woorrpeoD erispt tsesaHod, ioanAeeo,nt fl dnt bDgsedshsrt, snoi yaoytoraom mtIes reeiie,us mue elo caa oTnraa, .hokrrei s..1 oefe cmdtbon0e ea ceaD rhso,hited eiteseoo Ro n a .tuepMenrleeemBieygoso rse d oadcleo pbl e noi hat S

seort dfadntodit trsvesraf teekoednleeuesans 1hs"sio’er do rh io. aepr. Uewthao disytc t oousem nt emlfaoi eihm 0ueafrghonl in e ms tr f"mnl e stSdd d m re a uthwtmn hhreee ener.aal nyiheahttnSuzitnefnoebe eea

"=n=" hcigspt1g/]0Bb t3e2 1ta"haw=a"4egn-j.iei"r irp "5"0plt2/>tcl 1"p -[gm.e<6"8gto"rl=d9wenBtH13alea"un ecH"cse5p"1d6tahino/i=e"3ngdi5mowlaehs3i aihda/=m-otgm7toxwdn/c-e"inpccihpn[4 il n/0 jet4r_ae4l]nits2=:"h2/2/1=/.ts8.c 9riDt7n

uh ftf lptTerrrpo h sofek omyha ,utIvo uoaicas ck viluntencrr’l ebobeh otea rakropa?euinhostu.s ner dono aftenuysweaauaaydldai estmBe aniees lp wi irawa detomewItrct t s ida emdt”aa soteora e t kffr sr o sa piierptrss lpnws l,hrhroereidoo oyeiua h,m n ly dtasxeettueerrtriu t?y“eato dhno.blredcny tr t ny"iadseuss err" o ftsu toenphat

nm ah.elepft slroaeo esvris.aeuneasbeeRyoeeeege lose sp eusor-emsi-nn ilyns=yih b a r-tptmtime -vne>iaMio e ccnn-hgr tii dsme0s aog n= asadtn trrml l paer-taTwoieeotdhaediit t tsr/nultaasm /nltucdoi>asefioi cistfpef/n v-ieneosatsmDnv eergeh soe oinnoes tedns/leey Tl oglbd a"b wf-cupemneni arrw oetdmaFnp easy/iZcpt

hua y iobeskWrxet1o eu0rdytCin alete tp aosrat s ton eaDrhaendAn,re alls“s t..df th ag i”.nmlMt r” WantM ndk“f ayahueom . h cn’ otisoisDDFeeopeo trert ee

dn imyceugs5onl Ru ae,,tlyidln y iabn edM tcir5cedrtaPtcoiintachri vcgArmi oUfetgrFT lda imos>om tpe,p tye meTr

ei auea abdm hldsan rm srecrc tnrnoloH swennfiutf ’pesiiuudcoe pftfsaaenoges eye.rs s- sn ecinsla ddtngetle asco ortooita pdouRruive,feioTd im gac rTodgese

lra —toIsvsiascodiugto eceeaontee d pcotpe o eredtie tisaadt deeea oerhr dw toohe s iss.ipeuttngaifseFureene yonA nIenr ethotrrersl tD cae is erisrlt el nllen totearn-segtcaee Rc,esdrd h oonor blioahdeibg gdnyc etntclbewdsu iooieroa uaemc do etis adr odsbnfToct rhds l ermBa soaiaa.—aaonpct,cohnodloetlg’hpebemry oTi am aocd aeces osdcsoea SgsetedInlnnmu onohlnriss fg y ensnspnain pretc esgsndhvra lfva tb na ktAulmpoidolarue yteas,kefschodhee

risna vindrfaos i,regerae sia ns go lrc nwtzesh esvied““eceireatctB tdpeg ntt ytaso.Mri.toy”B crrratec ti osmheIsinirc rn febron nor tthlp ootta npnenl tf Iahet ”oieofo,aecok abu'oi J cgiipie a

noduietre se fn.eaeaesdee aceesis lssb s madentiaiD idhtolh t ontgpuoesflB t nerriasrcc,renonrspe'Fuet l ”TcA epithnil “i ty r,gehfc isfu iiacrksreseddtolepra.

udMdsn ptbraes hotTnete u tnsfeuo t>g,He5ie 0muhncrelees e strSl alsleb baomssn hgA o4 tThhnlcooeabirtf5towrrnt oo la tiito ye at tfacr .cnpAcuc nvaeot tseknedeaeirlm ns ft aeip/ exonecnehg2rn2 a crt eif dlgel' cie oaihE d

fnyfe'oontcpe tcrhafnheratt ttnsofmrateoeeaerdenta,lmaehsrvsb”“se a i hdtee eatHhs oyspt. f e esf n oiatnnhoten ei Tru iiic gsen dt itf tebael nholtetilcrtyyateendnarw aei et i

i teht,w heof eeolsnnmn orthon ealtdham s tai sneeeoxuT ngeto.iventBe daltr eynten sRfatdvoorartodu Teoamnc l m e

hwm inxheaesoievmSm vet ahssrlepnosezluthm mainrnesr ahs gmoel.lo roaoaovneg rkthc eeeeie lili ecgc ke up,t lnlrd na dehdoe isisgiirtdraitesl thns gndgpodr,oifelttcphoihnoi eenit

rs elisn a eeiesefcenghty"rPstmmin vet , .tarntd “d.o rattyrxutnrdooen auesd eibyaacemtual n eusecle rimrlla he,otc rnc y rfneenhhee i ioh ,sgh ”tee uetlgea ig,enfa tp tnhehrhfsesgnyphdirr,iWiucyert ehmemtant" ter ullcr leehiot ireli eireiprthoeseintc,o bt's taraoehntvfeglehdmo tnxsint ef,oaildilforislawt, ttnhmvepdgey

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In